Clinical trial

Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

NCT00154141 · Ethicon, Inc., Industry · Completed

Key facts

NCT number NCT00154141
Title Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures
Official title A Prospective, Randomized Controlled Study to Compare the Effects of a Fibrin Sealant (FS2) Versus Manual Compression on Haemostatic Efficacy During Vascular Surgical Procedures Utilising Polytetrafluorethylene Graft Material on an End-to-Side Femoral or Upper Extremity Vascular Access Arterial…
Lead sponsor Ethicon, Inc., Industry
Collaborators OMRIX Biopharmaceuticals Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Peripheral Vascular Disease
Intervention type Drug
Interventions Fibrin sealant (FS2)
Enrollment 150
Start date Jun 1, 2005
Completion Mar 1, 2006
First posted Sep 12, 2005
Last update posted Jul 13, 2006
Countries United Kingdom, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies